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A 31-year-old woman with a history of systemic lupus erythe-
matosus (SLE), chronic urticaria, and Sj€ogren's disease presented
with multiple erythematous, tender, swollen plaques on the right
thigh and the right lower leg for 2 days. The rash developed shortly
after she decreased the dosage of oral prednisolone from 10 mg/
15 mg on alternate days to 10 mg daily. She also noted numbness
and tingling of the ﬁngers, and pain and rash on the left ﬁfth distal
interphalangeal joint. The rash on the joint was conﬁrmed to be
cutaneous LE by skin biopsy in previous SLE ﬂares.
Biopsy of the right lower leg lesion showed spongiosis and intra-
epidermal vesicles in the upper epidermis; abundant eosinophilic
inﬁltrates and scanty lymphocytes were also found in the perivas-
cular, interstitial, and periadnexal areas. Laboratory examinations
revealed thrombocytopenia (132  109/L) and borderline low C3
(90.2 mg/dL). The rash resolved after intravenous administration
of methylprednisolone (40 mg daily) for 2 days.
Two months later, similar but more extensive tender, erythem-
atous, swollen plaques recurred on the lower legs after oral pred-
nisolone dosage was tapered (Figures 1A and 1B). This time, the
patient also developed fever, headache, blurred vision, general mal-
aise, arthralgia, and Raynaud's phenomenon. Borderline low C3
(97.3 mg/dL) and thrombocytopenia (103  109/L) were noted,
which was the case in the last episode as well. Histopathology of
the leg lesion showedmultiple ﬂame ﬁgures composed of degranu-
lated eosinophils and profound eosinophilic inﬁltrates from the
dermis to the subcutis (Figure 2). Thus, Wells syndrome was diag-
nosed based on the plaque-type clinical picture with constitutional
symptoms, relapsing remitting course, and supportive histology
with the presence of ﬂame ﬁgures. In total, she had at least four
such similar events in the past 1½ years (Figures 1C and 1D).
ThepatientwasdiagnosedwithSLEat theageof16years, basedon
initial presentations of arthralgia, photosensitivity, positive antinu-
clearantibody, severe thrombocytopenia, andhypocomplementemia.
Inher teenageyears,whenherSLErequiredrepeatedhospitalizations,
similar skin rash on sun-exposed parts of the extremities was
frequent, which occurredmostly during the summers especially after
excessive sunlight exposure. In the recent two episodes, biopsy-
proven Wells syndrome developed simultaneously with features of
SLE ﬂares, such as arthralgia, Raynaud's phenomenon, fever, or
thrombocytopenia. The two conditions responded to the same treat-
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).Wells syndrome is a cutaneous disorder characterized histolog-
ically by diffuse dermal inﬁltrates of eosinophils and “ﬂame ﬁg-
ures.” In addition to its association with arthropod bites,
myeloproliferative diseases, and viral infections, it is also rarely
associated with autoimmune diseases, such as ulcerative colitis
and ChurgeStrauss syndrome.1 The association with SLE, however,
has been reported only once.2
Previous studies have shown that the pathogenesis ofWells syn-
drome involves increased production of cytokines that recruit eo-
sinophils and promote their survival, including interleukin-5 (IL-
5). In 1997, Yagi et al3 identiﬁed a disproportionately high number
of CD4þCD7 Tcells, which expressed IL-5 messenger RNA (mRNA),
in the peripheral blood of a patient who presented with Wells syn-
drome and eosinophilia; treatment with interferon-g led to the
disappearance of IL-5 mRNA expression and decrease of CD4þCD7
T cells. Two other case reports showed that peripheral blood lym-
phocytes4 or mononuclear cells5 harvested from patients with
Wells syndrome could release signiﬁcant amounts of IL-5 in vitro
spontaneously. The T-cell rearrangement test also revealed several
ampliﬁed clonal T cells in one of these patients.5 These ﬁndings
suggest that the pathogenesis of Wells syndrome may involve
excessive IL-5 production by certain T-cell populations.
By contrast, cutaneous LE in SLE patients has been associated
with increased production of IL-5. Stein et al6 demonstrated that
the expression of mRNA for IL-5, but not for IL-2, IL-4, IL-10, or
interferon-g, was increased in cutaneous LE in SLE patients. This
result was further supported by another study in 2011.7 Finally,
Anzai et al8 described increased serum IL-5 level in an SLE patient
with eosinophilia compared to those without eosinophilia. These
ﬁndings indicate that increased expression of IL-5 is common in
cutaneous LE in SLE patients and that SLE could be associated
with increased serum IL-5 level.
Considering that IL-5 is the major cytokine involved in the path-
ophysiology of Wells syndrome and that IL-5 expression is
commonly increased in cutaneous LE in SLE patients, SLE patients
with cutaneous LE might be predisposed to development of Wells
syndrome. Rarity of such associations in previous studies might
be in part because Wells syndrome in the setting of SLE ﬂares is
easily misdiagnosed as acute cutaneous LE, because both are
responsive to corticosteroids. We thus recommend thorough exam-
inations, including skin biopsy, for SLE patients who present with
Wells syndrome-like lesions. The limitation of this case report is
that the peripheral eosinophil count and serum IL-5 level are un-
available. We believe further studies on the role of IL-5 in the path-
ogenesis of Wells syndrome and SLE would substantiate the
connection between the two diseases.evier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1 (A, B) Multiple painful and tender erythematous plaques with formation of vesicles on lower extremities. (C, D) Another episode of Wells syndrome that presented with
multiple painful erythematous plaques on the extremities.
Figure 2 (A) Spongiotic dermatitis with formation of intraepidermal vesicles and diffuse inﬁltrates with lymphocytes and eosinophils. Cells stained with hematoxylin and eosin,
40 magniﬁcation. (B) Eosinophilic, spongiotic vesicles without interface dermatitis. Cells stained with hematoxylin and eosin, 200 magniﬁcation. (C) A “ﬂame ﬁgure” formed by
many degranulated eosinophils. Cells stained with hematoxylin and eosin, 400 magniﬁcation.
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